Matinas BioPharma Holdings, Inc. Financial Ratios — MTNB

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-139.11	-155.26	-83.4	-127.78	-81.96	-57.73	-40.37	-35.2	-39.56	-65.62	-128.5	-104.24
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	- -	100	100	100	100	100	100	100	- -	- -
EBITDA Margin (%)	- -	- -	-5,073.68	- -	-10,957.4	-12,048.63	-20,197.99	-14,799.17	-72,587.88	-743.16	-2,082.57	- -	- -
Operating Margin (%)	- -	- -	-5,096.04	- -	-11,024.61	-12,230.94	-21,067.38	-15,288.38	-74,954.55	-771.33	-2,168.43	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	-850.6	- -	- -	- -	- -	- -	- -	- -	-328.83	- -
Pretax Margin (%)	- -	- -	-4,697.01	- -	-10,584.38	-12,183.71	-19,343.35	-14,176.98	-70,554.55	-658.63	-2,093.25	- -	- -
Profit Margin (%)	- -	- -	-4,697.01	- -	-10,345.91	-11,760.39	-19,343.35	-14,176.98	-70,554.55	-658.63	-2,093.25	- -	- -
Net Income to Common Margin (%)	- -	- -	-4,697.01	- -	-10,752.32	-12,516.17	-20,372.35	-14,678.1	-71,754.55	-658.63	-2,093.25	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	36.64	3.78	6.04	5.05	3.41	1.67	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	4	4	5	4	4	3	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1
LT Debt	- -	- -	- -	- -	- -	- -	4	3	4	4	3	2	1
Total Debt/EBITDA	- -	-0.01	- -	-0.02	-0.02	-0.03	-0.23	-0.16	-0.2	-0.17	-0.16	-0.15	-0.21
Net Debt/EBITDA	2.92	0.25	0.33	0.49	0.44	0.85	1.22	0.53	0.88	0.29	0.21	0.38	0.61
Total Debt/EBIT	- -	-0.01	- -	-0.02	-0.02	-0.03	-0.22	-0.15	-0.19	-0.17	-0.15	-0.14	-0.19
Net Debt/EBIT	2.92	0.25	0.33	0.48	0.43	0.84	1.17	0.51	0.85	0.28	0.2	0.36	0.57
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-33.77	-417.93	-275.77	-358.32	-355.42	-330.61	-209.64	-151.46	-214.61	-340.5	-699.38	-1,580.75	-2,924.33
Long-Term Debt/Equity (%)	- -	0.69	- -	0.23	0.63	0.67	11.35	5.22	7.89	9.7	15.04	28.04	13.62
Long-Term Debt/Capital (%)	- -	-0.11	- -	-0.06	-0.15	-0.19	-4.92	-3.33	-3.26	-2.39	-1.68	-1.08	-0.31
Long-Term Debt/Total Assets (%)	- -	0.45	- -	0.17	0.47	0.54	9.32	4.69	6.76	7.93	11.53	16.83	9.13
Total Debt/Equity (%)	- -	2.68	0.19	2.02	2.48	2.42	12.79	5.88	8.96	11.26	18.48	38.13	28.03
Total Debt/Capital (%)	- -	-0.43	-0.05	-0.5	-0.58	-0.7	-5.55	-3.75	-3.71	-2.78	-2.07	-1.47	-0.65
Total Debt/Total Assets (%)	- -	1.77	0.13	1.47	1.84	1.96	10.51	5.28	7.67	9.2	14.17	22.89	18.78
Net Debt to Equity	-103.49	-116.29	-53.14	-55.77	-66.81	-75.87	-67.08	-19.51	-40.06	-18.64	-24.87	-95.97	-82.8
Net Debt/Capital (%)	73.91	15.63	12.22	12.07	13.57	17.96	22.55	11.06	14.22	4.4	2.71	3.57	1.87
EBITDA	-4	-10	-10	-8	-16	-14	-18	-23	-24	-24	-23	-19	-7
EBITDA-CapEx	-4	-11	-10	-8	-17	-15	-19	-23	-24	-25	-23	-19	-7
Operating Income (Loss)	-4	-10	-10	-8	-17	-15	-19	-24	-25	-25	-24	-20	-7

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	12.62	2.32	2.86	2.84	4.13	4.38	8.97	16.45	11.41	6.71	5.25	2.73	2.73
Current Ratio	12.72	2.51	3.15	3.16	4.5	4.61	9.66	17.25	11.73	8.06	5.93	3.01	2.79
Quick Ratio	12.62	2.32	2.86	2.84	4.13	4.38	8.97	16.45	11.41	6.71	5.25	2.73	2.73
CFO/Avg Current Liab	- -	-8.05	-6.96	-4.76	-7.13	-4.48	-4.75	-5.21	-3.85	-4.44	-4.42	-6.01	-3.4
Common Equity/Total Assets	-33.77	-417.93	-275.77	-358.32	-355.42	-330.61	-209.64	-151.46	-214.61	-340.5	-699.38	-1,580.75	-2,924.33
Long-Term Debt/Equity (%)	- -	0.69	- -	0.23	0.63	0.67	11.35	5.22	7.89	9.7	15.04	28.04	13.62
Long-Term Debt/Capital (%)	- -	-0.11	- -	-0.06	-0.15	-0.19	-4.92	-3.33	-3.26	-2.39	-1.68	-1.08	-0.31
Long-Term Debt/Total Assets (%)	- -	0.45	- -	0.17	0.47	0.54	9.32	4.69	6.76	7.93	11.53	16.83	9.13
Total Debt/Equity (%)	- -	2.68	0.19	2.02	2.48	2.42	12.79	5.88	8.96	11.26	18.48	38.13	28.03
Total Debt/Capital (%)	- -	-0.43	-0.05	-0.5	-0.58	-0.7	-5.55	-3.75	-3.71	-2.78	-2.07	-1.47	-0.65
Total Debt/Total Assets (%)	- -	1.77	0.13	1.47	1.84	1.96	10.51	5.28	7.67	9.2	14.17	22.89	18.78
CFO/Total Liabilities	-347.84	-702.32	-334.85	-229.48	-306.27	-271.5	-196.03	-240	-172.36	-234.12	-260.81	-314.49	-294.83
CFO/CapEx	-31.72	-27.59	-102.58	- -	-12.16	-19.26	-34.74	-3,021.02	-58.55	-21.48	-70.08	- -	- -
Altman's Z-Score	-0.49	-7.88	-4.06	4.84	5.05	0.99	23.38	19.79	10.74	1.64	-10.01	-32.44	-63.65

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	14	44	81	105	58	330	268	212	108	47	2	- -
- Cash & Cash Equivalents	11	3	3	4	7	12	22	12	21	7	5	7	4
+ Preferred Equity and Hybrid Capital	- -	- -	- -	6	6	10	4	4	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	4	4	5	4	4	3	1
Enterprise Value	-11	12	41	83	104	56	310	217	167	84	37	-2	-3
Total Capital	-4	-14	-23	-29	-45	-56	-76	-100	-127	-148	-172	-197	-209
Total Debt/Capital (%)	- -	-0.43	-0.05	-0.5	-0.58	-0.7	-5.55	-3.75	-3.71	-2.78	-2.07	-1.47	-0.65
Total Debt / EV	- -	0.01	- -	- -	- -	0.01	0.01	0.02	0.03	0.05	0.1	-1.52	-0.51
EV/Sales	- -	- -	208.45	- -	692.29	468.44	3,452.01	1,368.29	5,071.55	26.28	33.55	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	14	44	81	105	58	330	268	212	108	47	2	- -
Diluted Enterprise Value	-11	12	41	83	104	56	316	263	196	106	46	-2	-3
EV per Share	- -	18.55	39.38	71.84	57.27	28.59	106.76	55.02	39.81	19.32	8.46	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	1	- -	- -
TTM EBITDA	-4	-10	-10	-8	-16	-14	-18	-23	-24	-24	-23	-19	-7
TTM Operating Income	-4	-10	-10	-8	-17	-15	-19	-24	-25	-25	-24	-20	-7
TTM Cash Flow to Firm	-3	-8	-8	-6	-11	-10	-14	-17	-15	-19	-15	-16	-7
TTM Free Cash Flow to Firm	-3	-8	-8	-6	-11	-10	-14	-17	-15	-18	-15	-16	-7

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	-1.88	-5.65	-13.19	-9.98	-5.97	-24.08	-15.42	-14.19	-5.94	-3.12	-0.16	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-11	12	41	83	104	56	310	217	167	84	37	-2	-3
Low Price	- -	15.51	15.6	20.55	50.5	16.18	28.5	24.5	33.38	21.67	5.52	0.48	0.47
EV/Sales	- -	- -	208.45	- -	692.29	468.44	3,452.01	1,368.29	5,071.55	26.28	33.55	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-2.13	-4.58	-4.41	-11.3	-4.64	-7.77	-7.81	-9.15	-7.61	-3.41	-1.43	- -
Price/Earnings High	- -	-4.24	-8.23	-9.66	-22.43	-9.69	-19.76	-20.25	-19.71	-10.95	-8.43	-4.31	- -
Price/Earnings Low	- -	-0.97	-1.76	-1.98	-5.68	-2.12	-4.52	-4.15	-5.93	-4.48	-1.05	-0.1	- -
Price/Book Value	- -	-1.03	-1.89	-2.29	-2.05	-0.89	-3.91	-2.49	-1.61	-0.71	-0.27	-0.01	- -
Price/Book Value Average	- -	-1.55	-1.8	-1.5	-3.55	-1.06	-1.68	-1.69	-1.65	-1.05	-0.45	-0.17	- -
Price/Book Value High	- -	-3.08	-3.24	-3.29	-7.04	-2.2	-4.29	-4.38	-3.55	-1.51	-1.1	-0.52	- -
Price/Book Value Low	- -	-0.71	-0.69	-0.67	-1.78	-0.48	-0.98	-0.9	-1.07	-0.62	-0.14	-0.01	- -
Price/Tangible Book Value	- -	6.48	25.46	-24.53	171.69	29.07	13.34	4.82	4.41	3.36	3.15	0.47	- -
Price/Tangible Book Value Average	- -	9.79	24.33	-16.08	297.56	34.65	5.75	3.27	4.5	4.95	5.25	6.5	- -
Price/Tangible Book Value High	- -	19.44	43.74	-35.22	590.56	72.32	14.63	8.47	9.69	7.12	12.98	19.63	- -
Price/Tangible Book Value Low	- -	4.47	9.35	-7.2	149.49	15.81	3.35	1.74	2.91	2.91	1.61	0.44	- -
Price/Sales	- -	- -	224.99	- -	701.14	487.44	3,669.81	1,691.22	6,432.73	34	42.86	- -	- -
Price/Sales Average	- -	- -	214.94	- -	1,215.15	580.97	1,582.56	1,147	6,562.35	50.15	71.31	- -	- -
Price/Sales High	- -	- -	386.45	- -	2,411.67	1,212.47	4,025.47	2,972.08	14,139.27	72.09	176.43	- -	- -
Price/Sales Low	- -	- -	82.58	- -	610.47	265.1	921.49	609.34	4,251.97	29.47	21.89	- -	- -
Price/Cash Flow	- -	-1.81	-5.6	-13.19	-9.16	-5.66	-23.39	-15.42	-13.94	-5.66	-3.07	-0.16	- -
Price/Cash Flow Average	- -	-2.74	-5.35	-8.65	-15.87	-6.74	-10.09	-10.46	-14.23	-8.35	-5.12	-2.18	- -
Price/Cash Flow High	- -	-5.44	-9.62	-18.94	-31.5	-14.07	-25.66	-27.09	-30.65	-12	-12.66	-6.59	- -
Price/Cash Flow Low	- -	-1.25	-2.06	-3.87	-7.97	-3.08	-5.87	-5.56	-9.22	-4.91	-1.57	-0.15	- -
Price/Free Cash Flow Average	- -	-2.84	-5.4	-8.65	-17.29	-7.11	-10.38	-10.46	-14.47	-8.75	-5.19	-2.18	- -
Price/Free Cash Flow High	- -	-5.64	-9.71	-18.94	-34.32	-14.84	-26.42	-27.1	-31.18	-12.58	-12.84	-6.59	- -
Price/Free Cash Flow Low	- -	-1.3	-2.08	-3.87	-8.69	-3.24	-6.05	-5.56	-9.38	-5.14	-1.59	-0.15	- -
EV/Sales Average	- -	- -	198.4	- -	1,206.3	561.97	1,427.16	1,116.15	6,067.59	49.3	70.19	- -	- -
EV/Sales High	- -	- -	369.92	- -	2,402.82	1,193.46	3,870.08	2,941.23	13,644.51	71.24	175.31	- -	- -
EV/Sales Low	- -	- -	66.05	- -	601.62	246.1	766.1	578.49	3,757.21	28.63	20.76	- -	- -
EV/EBITDA Average	2.92	-1.85	-3.91	-6.71	-11.01	-4.66	-7.07	-7.54	-8.36	-6.63	-3.37	-1.58	0.41
EV/EBITDA High	2.92	-3.91	-7.29	-14.38	-21.93	-9.91	-19.16	-19.87	-18.8	-9.59	-8.42	-5.22	0.41
EV/EBITDA Low	2.92	-0.71	-1.3	-3.15	-5.49	-2.04	-3.79	-3.91	-5.18	-3.85	-1	0.11	0.41
EV/EBIT Average	2.92	-1.84	-3.89	-6.66	-10.94	-4.59	-6.77	-7.3	-8.1	-6.39	-3.24	-1.5	0.38
EV/EBIT High	2.92	-3.9	-7.26	-14.29	-21.8	-9.76	-18.37	-19.24	-18.2	-9.24	-8.08	-4.97	0.38
EV/EBIT Low	2.92	-0.71	-1.3	-3.13	-5.46	-2.01	-3.64	-3.78	-5.01	-3.71	-0.96	0.1	0.38
Last Price	- -	22.5	42.5	70	58	29.75	113.5	68	50.5	25	10.81	0.51	0.59
High Price	- -	67.5	73	100.5	199.5	74	124.5	119.5	111	53	44.5	21.5	3.09
Enterprise Value Average	-11	19	39	55	181	67	128	177	200	157	77	30	-3
Enterprise Value High	-11	41	72	118	360	143	348	466	450	227	192	100	-3
Enterprise Value Low	-11	7	13	26	90	29	69	92	124	91	23	-2	-3

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	1	1	1	1	2	2	3	4	4	4	4	5	6
Diluted Weighted Avg Shares	1	1	1	1	2	2	3	4	4	4	4	5	- -
Basic Weighted Avg Shares	1	1	1	1	2	2	3	4	4	4	4	5	- -
Revenue per Share	- -	- -	0.19	- -	0.08	0.06	0.03	0.04	0.01	0.74	0.25	- -	- -
EBITDA per Share	-5.8	-16.25	-9.58	-7.12	-9.06	-7.35	-6.25	-5.95	-5.7	-5.46	-5.25	-3.94	- -
Operating Income per Share	-5.8	-16.31	-9.63	-7.16	-9.12	-7.46	-6.52	-6.15	-5.88	-5.67	-5.47	-4.14	- -
Basic EPS, GAAP	-5.8	-15.93	-8.87	-10.4	-8.89	-7.64	-6.3	-5.9	-5.63	-4.84	-5.28	-4.98	- -
Basic EPS from Cont Ops	-5.8	-15.93	-8.87	-6.59	-8.56	-7.18	-5.98	-5.7	-5.54	-4.84	-5.28	-4.98	- -
Diluted EPS, GAAP	-5.8	-15.93	-8.87	-10.4	-8.89	-7.64	-6.3	-5.9	-5.63	-4.84	-5.28	-4.98	- -
Diluted EPS from Cont Ops	-5.8	-15.93	-8.87	-6.59	-8.56	-7.18	-5.98	-5.7	-5.54	-4.84	-5.28	-4.98	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-4.67	-12.41	-7.59	-5.31	-6.33	-5.26	-4.85	-4.41	-3.62	-4.42	-3.52	-3.26	- -
Free Cash Flow per Basic Share	-4.82	-12.86	-7.66	-5.31	-6.85	-5.53	-4.99	-4.41	-3.68	-4.62	-3.57	-3.26	- -
Cash & Equivalents per Share	16.94	4.04	3.13	3.56	4.04	6.34	9.56	14.9	11.8	6.63	3.17	1.5	- -
Book Value per Share	-5.98	-21.9	-22.51	-30.5	-28.33	-33.6	-29.05	-27.3	-31.31	-35.19	-40.41	-41.07	- -
Tangible Book Value per Share	16.37	3.47	1.67	-2.85	0.34	1.02	8.51	14.11	11.45	7.45	3.43	1.1	- -

Matinas BioPharma Holdings, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)